{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Return to mskcc.org Home
Memorial Sloan Kettering Cancer Center
  • Sign In
  • Live Courses
  • On Demand Courses
  • Coming Soon
  • Gift Certificates
  • Visiting Us
  • About
  • Contact
  • Help
Close Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

Select a button below to sign in or create an account. If you have previously registered or attended a MSK CME event, please sign in using the username and password created at course registration. MSK employees must use their SSO credentials to sign in. 

Sign in (MSK Employees Only)
Sign in or Create an Account (Non-MSK Employee)
Enter your email and password to login:



Login

New to CloudCME? Create an Account:

Create New Account
Back to Login Provider Forgot Your Password?

Forgot Your Password?







Back to Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##






Password Requirements

  • Must be between 8 and 16 characters in length
  • Must Contain at least 1 upper case character
  • Must Contain at least 1 lower case character
  • Must contain at least 1 numeric character
  • Must contain at least 1 of the following ! * @ # $ % ^ & + =


  • -- Select Degree --
  • ACHPN
  • ACNP
  • ACNP-BC
  • AGACNP
  • AGACNP-BC
  • AGCNS
  • AGNP
  • AGNP-BC
  • ANP
  • ANP-BC
  • AS
  • AT
  • AuD
  • BA
  • BAO
  • BCC
  • BCh
  • Bchir
  • BM
  • BS
  • BS, MS
  • BSN
  • BSN, MS
  • BSN, MS, DNP
  • CCC-SLP
  • CCLS
  • CCRN
  • CCRP
  • CEN
  • ChB
  • CIPS
  • CNM
  • CNP
  • CPNP
  • CPNP-AC
  • CRNA
  • CRNP
  • CTTS
  • D(ABMM)
  • DAc
  • DACM
  • DAHM
  • DAOM
  • DDS
  • DDS, MPH
  • DMD
  • DMD, PhD
  • DNP
  • DNP, RN
  • DNSc
  • DO
  • DPM
  • DPT
  • DrPH
  • DSc
  • DVM
  • EdD
  • EdS
  • FAAP
  • FACNM
  • FACOG
  • FACS
  • FASCRS
  • FASN
  • FCCM
  • FCCP
  • FIPP
  • FNP
  • FNP-BC
  • GNP
  • GNP-BC
  • HUC
  • JD
  • LAc
  • LCSW
  • LISW
  • LISW-S
  • LPCC
  • LPN
  • LSW
  • MA
  • MAc
  • MAcOM
  • MB
  • MB, PhD
  • MBA
  • MBBCh
  • MBBCh BAO
  • MBBCh BAO, PhD
  • MBBCh, MPH
  • MBBCh, PhD
  • MBBS
  • MBBS, MPH
  • MBBS, PhD
  • MBChB
  • MD
  • MD, DSc
  • MD, JD
  • MD, MA
  • MD, MAS
  • MD, MBA
  • MD, MHA
  • MD, MPH
  • MD, MPH, MHS
  • MD, MS
  • MD, MS, PhD
  • MD, PhD
  • MD, PhD, MA
  • MD, PhD, MPH
  • MD, PhD, MS
  • MDiv
  • MEd
  • MHS
  • MPA
  • MPH
  • MPhil
  • MS
  • MSc
  • MSc, PhD
  • MSN
  • MSPH
  • NCTTP
  • None
  • NP
  • NP, RN
  • OCN
  • OD
  • Other
  • OTR
  • PA
  • PA-C
  • PCA
  • PharmD
  • PharmD, PhD
  • PhD
  • PhD, MBA, MS
  • PhD, MPH
  • PhD, MPhil
  • PhD, MS
  • PhD, MSc
  • PhD, NP, RN
  • PsyD
  • PT
  • RA
  • RCS
  • RD
  • RDCS
  • RDMS
  • RN
  • RN-BC
  • RPh
  • RRT
  • RT
  • ScD

Please enter your degree:





Back to Login
Close Search Site Search: Enter your search terms in the field below to view results.
Close Specialties
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

11th Annual Hematology and Medical Oncology Board Review: Contemporary Practice


11th Annual Hematology and Medical Oncology Board Review: Contemporary Practice Banner

  • Overview
  • Register
  • Faculty
  • Brochure
  • Schedule
  • Course Content
Add to Calendar 11th Annual Hematology and Medical Oncology Board Review: Contemporary Practice 3/10/2023 9:00:00 AM 3/13/2023 1:00:00 PM America/New_York For More Details: https://mskcc.cloud-cme.com/course/courseoverview?P=0&EID=36565 Description: This four-day live virtual only course will provide an up-to-date and comprehensive review of the diagnosis, staging, and management of neoplastic disease, including solid tumor and hematologic oncology. Online false MM/DD/YYYY


Date & Location
Friday, March 10, 2023, 9:00 AM - Monday, March 13, 2023, 1:00 PM, Online, New York, NY

Specialties
Specialties - Hematology, Infectious Diseases, Medical Oncology, Oncology and Hematology, Radiation Oncology, Surgical Oncology

Overview

Condensed over 3.5 days, this virtual course will provide an up-to-date and comprehensive review of the diagnosis, staging, and management of neoplastic disease, including solid tumor and hematologic oncology. Lectures provided by expert faculty from Memorial Sloan Kettering will focus on disease-specific topics in gastrointestinal, gynecologic, thoracic, head and neck, genitourinary, soft tissue and skin, and central nervous system oncology, as well as hematologic oncology. Ample time will be provided for live Q&A with the speakers.

Additionally, registered attendees will receive access to an online syllabus after the course, which includes select PDFs of the faculty presentations (slides) and recorded videos from the course (MSK CME will email attendees when this becomes available).

Who Should Attend

The target audience for this well-received annual program includes medical oncology professionals - physicians, nurses, pharmacists, fellows and residents.

Live Virtual Format

This course will be delivered virtually using Zoom: zoom.us/download. CME credit and ABIM MOC points will be offered for this live virtual program. Detailed access and credit instructions will be emailed to attendees prior to the start of the program.


Objectives
  1. Define state-of-the-science in diagnosis, staging, and therapeutic management of solid tumor cancers and hematologic cancers.
  2. Discuss recent treatment advances in solid tumor and hematologic oncology and apply knowledge gained in modern clinical practice
  3. Prepare for ABIM examinations in medical oncology and hematology.

Registration

Virtual Registration Fees

  • Physicians (MDs, PhDs, and DOs): $1,650
  • Residents, Fellows, Nurses, and Other Healthcare Providers: $1,075
  • Industry Professionals*: $2,885

*Industry professionals may attend MSK CME activities for their own education. Marketing, sales, and promotion of products and services is strictly prohibited at MSK CME activities. For more information, please visit our Help page.

Discounts/Promotions/Complimentary Registration 

  • A 30% registration discount is available for MSK Alumni and MSK Cancer Alliance members to attend a MSK CME course. If you are a member of one of these groups, please contact [email protected] for details. Please note that after your payment has been processed, no further promotional discount adjustments will be made to your registration.
  • Registration is complimentary for all MSK employees; however, you must complete registration in order to attend this course. If you are registered for this course and are unable to attend, please email [email protected]. 
  • A limited number of complimentary registration spots for the 2023 HemOnc Board Review are available for MSK International Observers as well as graduate students and practicing oncologists in India. Interested providers who are part of these two international groups must apply for consideration, please email [email protected] Approved applicants will be notified of their acceptance of complimentary registration by March 1, 2023.

Cancellation Policy

If you wish to cancel your participation in this course, you must email [email protected] at least seven (7) days prior to the start of the course, and your refund will be subject to a $25 administrative fee. Cancellations or no-shows within seven (7) days of the course are not eligible for a refund. Please note that if it has been more than 120 days since payment was processed, a W9 form must be submitted in order process your refund and your refund will be issued in the form of a check payment. Refunds are not subject to tax. You may substitute another registrant in your place at any time by contacting [email protected] with the appropriate information.

MSK CME reserves the right to cancel or postpone any course due to unforeseen circumstances. In the unlikely event we must cancel or postpone this course, you will be notified via email from MSK CME ([email protected]). A full refund will be issued for your registration. MSK CME is not responsible for any related costs, charges, or expenses to participants, including fees incurred by airline/travel/lodging agencies.


Accreditation

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this live activity for a maximum of 30.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Recognition Statement

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 30.75 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.



Keywords: Virtual OnlyABIM MOCAMA PRA Category 1



MSK Course Directors 

David H. Ilson, MD, PhD, FACP, FASCO
Attending Physician, Member, Gastrointestinal Oncology Service
Professor of Medicine, Weill Cornell Medical College


Paul A. Hamlin, MD
Medical Director, David H. Koch Center for Cancer Care
Associate Attending, Lymphoma Service 
Associate Professor of Medicine, Weill Cornell Medical College

 

MSK Course Faculty

Ghassan K. Abou-Alfa, MD, MBA
Attending Physician, Gastrointestinal Oncology Service

Carol Aghajanian, MD
Attending Physician, Chief, Gynecologic Medical Oncology Service

Lior Z. Braunstein, MD
Assistant Attending Radiation Oncologist, External Beam Radiotherapy Service

Andrea Cercek, MD
Section Head, Colorectal Cancer; 
Co-Director, Center for Young Onset Colorectal and Gastrointestinal Cancers; 
Associate Attending Physician, Gastrointestinal Oncology Service

Paul B. Chapman, MD
Attending Physician, Melanoma Service

Noura J. Choudhury, MD
Assistant Attending Physician, Thoracic Oncology Service & Early Drug Development Service

Hiram S. Cody III, MD, FACS
Attending Surgeon, Breast Service;
Professor of Surgery, Weill Cornell Medical College

Chau T. Dang, MD
Regional Care Network Medical Site Director, MSK Westchester;
Attending Physician, Breast Medicine Service

Mark A. Dickson, MD
Associate Attending Physician, Sarcoma Medical Oncology Service

Lara A. Dunn, MD
Assistant Attending Physician, Head and Neck Oncology Service

Darren R. Feldman, MD
Chair, Quality Assurance;
Section Head, Germ Cell Cancer;
Associate Attending Physician, Genitourinary Oncology Service; 
Associate Professor of Medicine, Weill Cornell Medical College

Devika Gajiria, MD
Assistant Attending Physician, Breast Medicine Service

Mark B. Geyer, MD
Adolescent and Young Adult Program Leader;
Assistant Attending, Leukemia Service & Cellular Therapy Service;
Assistant Professor of Medicine, Weill Cornell Medicine

Mrinal M. Gounder, MD
Associate Attending Physician, Sarcoma Medical Oncology & Early Drug Development (Phase I);
Physician Ambassador, India and Asia, Bobst International Center, MSK

Rachel N. Grisham, MD
Section Head, Ovarian Cancer;
Director, Gynecologic Medical Oncology, MSK Westchester;
Associate Attending Physician, Gynecologic Medical Oncology Service

Malin Hultcrantz, MD
Assistant Attending Physician, Myeloma Service;
Assistant Professor of Medicine, Weill Cornell Medicine

Gopa Iyer, MD
Section Head, Bladder Cancer;
Associate Attending Physician, Genitourinary Oncology Service & Early Drug Development Service 

Thomas J. Kaley, MD
Vice Chair, Department of Neurology; 
Associate Attending Neuro-Oncologist


Simon Mantha, MD, MPH
Attending Physician, Hematology Service

Michael J. Mauro, MD
Leader, Myeloproliferative Neoplasms Program;
Attending Physician, Leukemia Service

Jodi V. Mones, MD
Associate Fellowship Program Director;
Associate Attending Physician, Hematology Service

Alison J. Moskowitz, MD
Associate Attending Physician, Lymphoma Service

Robert J. Motzer, MD
Section Head, Kidney Cancer;
Jack and Dorothy Byrne Chair in Clinical Oncology;
Attending Physician, Genitourinary Oncology Service

Eileen M. O’Reilly, MD
Winthrop Rockefeller Endowed Chair in Medical Oncology;
Co-Director, Medical Initiatives, David M. Rubenstein Center for Pancreatic Cancer Research;
Section Head, Hepatopancreaticobilary & Neuroendocrine Cancers;
Attending Physician, Member, Gastrointestinal Oncology Service;
Professor of Medicine, Weill Cornell Medical College

Rekha Parameswaran, MD
Attending Physician, Hematology Service

Gregory J. Riely, MD, PhD
Vice Chair, Clinical Research; 
Attending Physician, Thoracic Oncology Service 

Lindsey Roeker, MD
Assistant Attending Physician, Leukemia Service

Leonard Saltz, MD
Executive Director for Clinical Value & Sustainability;
Head, Colorectal Oncology Section;
Attending Physician, Gastrointestinal Oncology Service;
Professor of Medicine, Weill Cornell Medical Center

Rachel Sanford, MD
Assistant Attending Physician, Breast Medicine Service

Michael Scordo, MD
Assistant Attending Physician, Bone Marrow Transplant Service & Cellular Therapy Service

Susan K. Seo, MD
Director, Antibiotic Management Program; 
Attending Physician, Infectious Disease Service 


Gunjan L. Shah, MD
Assistant Attending Physician, Bone Marrow Transplant Service & Cellular Therapy Service

Susan F. Slovin, MD, PhD
Associate Vice Chair, Academic Affairs;
Attending Physician, Genitourinary Oncology Service & Cellular Therapy Service

Zsofia K. Stadler, MD
Clinical Director, Clinical Genetics Service;
Associate Attending Physician, Clinical Genetics Service & Gastrointestinal Oncology Service

Eytan M. Stein, MD
Chief, Leukemia Service;
Director, Program for Drug Development in Leukemia 

Anna M. Varghese, MD
Assistant Attending Physician, Gastrointestinal Oncology Service

Cy R. Wilkins, MD
Assistant Attending Physician, Hematology Service;
Assistant Professor of Clinical Medicine, Weill Cornell Medical College

Marjorie G. Zauderer, MD
Co-Director MSK Mesothelioma Program; 
Associate Attending Physician, Thoracic Oncology Service

Andrew D. Zelenetz, MD, PhD
Medical Director, Quality Informatics;
Attending Physician, Lymphoma Service



Mitigation of Relevant Financial Relationships


Memorial Sloan Kettering Cancer Center adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.

Faculty Member Information
Role in activity
Name of Ineligible Company(s) / Nature of Relationship(s)
Paul A Hamlin, MD
MSK
Activity Co-Director, Faculty
Grant or research support-Portola Pharmaceuticals, Inc. (Relationship has ended)|Grant or research support-Alexion|Consulting Fee-Juno Pharmaceuticals (Relationship has ended)|Consulting Fee-AstraZeneca (Relationship has ended)|Consulting Fee-Sandoz (Relationship has ended)|Consulting Fee-Celgene (Relationship has ended)|Advisor-Calithera|Consulting Fee-Karyopharm (Relationship has ended)|Grant or research support-Janssen |Grant or research support-Molecular Templates
David Ilson, MD, PhD
MSK
Activity Director, Faculty
Consulting Fee-Roche|Consulting Fee-Servier (Relationship has ended)|Consulting Fee-Merck and Company, Inc.|Consulting Fee-Bristol-Myers Squibb|Consulting Fee-Natera|Consulting Fee-Daiichi Sankyo|Consulting Fee-Bayer Corporation|Consulting Fee-AstraZeneca
Louise Connell, BAO,MBBCh
MSK
Conflict of Interest Peer Reviewer
Nothing to disclose
Elizabeth Won, MD
MSK
Conflict of Interest Peer Reviewer
Nothing to disclose
Ghassan K Abou-Alfa, MD, MBA, Professor
MSK
Faculty
Grant or research support-Arcus|Grant or research support-Agenus|Grant or research support-AstraZeneca|Grant or research support-BioNtech|Grant or research support-Bristol-Myers Squibb|Grant or research support-Elicio|Grant or research support-Genentech, Inc.|Grant or research support-Helsinn|Grant or research support-Parker Institute|Grant or research support-Pertzye|Grant or research support-Puma|Grant or research support-QED|Grant or research support-Yiviva|Consulting Fee-Astellas|Consulting Fee-AstraZeneca|Consulting Fee-Autem|Consulting Fee-Berry Genomics|Consulting Fee-Biontech|Consulting Fee-Celgene|Consulting Fee-Bo|Consulting Fee-Eisai, Inc.|Consulting Fee-Exelixis|Consulting Fee-Fibrinogen|Consulting Fee-Genentech, Inc.|Consulting Fee-Helio|Consulting Fee-Incyte|Consulting Fee-Ipsen|Consulting Fee-Merck and Company, Inc.|Consulting Fee-Merus|Consulting Fee-Neogene|Consulting Fee-Newbridge|Consulting Fee-Servier|Consulting Fee-Novartis AG|Consulting Fee-QED|Consulting Fee-Vector|Advisor-Tempus|Advisor-Thetis|Consulting Fee-Yiviva
Carol Aghajanian, MD
MSK
Faculty
Grant or research support-Abbvie|Grant or research support-Genentech, Inc.|Grant or research support-Clovis|Grant or research support-AstraZeneca
Mark B Blaine Geyer, MD
MSK
Faculty
Advisor-Sanofi-Aventis|Advisor-Novartis AG|Advisor-Allogene (Relationship has ended)|Grant or research support-Amgen|Grant or research support-Actinium Pharmaceuticals, Inc
Lior Braunstein, MD
MSK
Faculty
Nothing to disclose
Andrea Cercek, MD
MSK
Faculty
Advisor-Merck and Company, Inc. (Relationship has ended)|Advisor-GlaxoSmithKline|Advisor-Bayer Corporation|Advisor-Janssen|Advisor-Seagen|Grant or research support-GlaxoSmithKline|Grant or research support-Seagen|Grant or research support-RGenix (Relationship has ended)|Advisor-G1 Therapeutics (Relationship has ended)|Advisor-Pfizer, Inc.|Royalties or Patent Beneficiary-MSK
Paul Chapman, MD
MSK
Faculty
Consulting Fee-Merck and Company, Inc.|Consulting Fee-Black Diamond Therapeutics, Inc.|Consulting Fee-Pfizer, Inc.|Stocks or stock options, excluding diversified mutual funds-Rgenix|Consulting Fee-Gigagen
Naura Choudhury, MD
MSK
Faculty
Honoraria-Sanofi-Aventis (Relationship has ended)|Honoraria-G1 Therapeutics (Relationship has ended)|Grant or research support-Abbvie|Grant or research support-Merck and Company, Inc.|Grant or research support-Monte Rosa Therapeutics|Grant or research support-Amgen|Grant or research support-Harpoon Therapeutics
Hiram S Cody III III, MD, FACS
MSK
Faculty
Nothing to disclose
Chau Dang , MD
MSK
Faculty
Grant or research support-Roche|Honoraria-Roche (Relationship has ended)|Consulting Fee-Pfizer (Relationship has ended)|Honoraria-Daiichi Sankyo (Relationship has ended)|Honoraria-Gilead|Consulting Fee-Seagen (Relationship has ended)|Consulting Fee-Novartis AG (Relationship has ended)|Grant or research support-PUMA
Mark Dickson, MD
MSK
Faculty
Grant or research support-Eli Lilly and Company|Grant or research support-Sumitomo|Grant or research support-AADI
Lara Dunn, MD
MSK
Faculty
Advisor-Merck and Company, Inc.|Grant or research support-Regeneron|Advisor-Regeneron|Grant or research support-CUE Biopharma|Grant or research support-Replimune |Grant or research support-Nektar
Darren Feldman, MD
MSK
Faculty
Grant or research support-Astellas (Relationship has ended)|Grant or research support-Decibel|Honoraria-UpToDate|Grant or research support-Telix, Inc.|Consulting Fee-BioNtech (Relationship has ended)
Devika Gajria, MD
MSK
Faculty
Nothing to disclose
Mrinal Gounder, MD
MSK
Faculty
Consulting Fee-Ayala|Consulting Fee-Bayer Corporation (Relationship has ended)|Consulting Fee-Boehringer Ingelheim Vetmedica GmbH (Relationship has ended)|Consulting Fee-Rain Oncology|Consulting Fee-Epizyme|Consulting Fee-Karyopharm (Relationship has ended)|Consulting Fee-Springworks Therapeutics (Relationship has ended)|Consulting Fee-Regeneron
Rachel Grisham, MD
MSK
Faculty
Advisor-Onconova (Relationship has ended)|Advisor-GlaxoSmithKline|Advisor-Natera (Relationship has ended)|Advisor-Corcept (Relationship has ended)|Advisor-AstraZeneca (Relationship has ended)|Advisor-Springworks (Relationship has ended)|Advisor-Verastem
Malin Hultcrantz, MD
MSK
Faculty
Grant or research support-GlaxoSmithKline|Advisor-GlaxoSmithKline|Grant or research support-Daiichi Sankyo|Advisor-Bristol-Myers Squibb (Relationship has ended)
Gopa Iyer, MD
MSK
Faculty
Advisor-Flare Therapeutics|Consulting Fee-EMD Serono (Relationship has ended)|Advisor-LOXO Oncology|Honoraria-Gilead (Relationship has ended)|Honoraria-DAVA Oncology (Relationship has ended)|Honoraria-The Lynx Group (Relationship has ended)|Advisor-Aadi Biosciences|Advisor-Johnson and Johnson
Thomas Kaley, MD
MSK
Faculty
Nothing to disclose
Simon Mantha, MD, MPH
MSK
Faculty
Nothing to disclose
Michael Mauro, MD
MSK
Faculty
Grant or research support-Novartis AG|Honoraria-Novartis AG|Advisor-Bristol-Myers Squibb|Advisor-Pfizer, Inc.|Grant or research support-Sun Pharma / SPARC|Grant or research support-Takeda Pharmaceuticals, Inc.|Consulting Fee-Abbvie
Jodi Mones, MD
MSK
Faculty
Nothing to disclose
Alison Moskowitz, MD
MSK
Faculty
Grant or research support-Seagen|Grant or research support-Merck and Company, Inc.|Grant or research support-Bristol-Myers Squibb|Grant or research support-Incyte Corporation|Grant or research support-SecuraBio|Honoraria-Seagen|Honoraria-Takeda Pharmaceuticals, Inc.|Honoraria-Merck and Company, Inc.|Honoraria-Affimed
Robert Motzer, MD
MSK
Faculty
Consulting Fee-Pfizer, Inc. (Relationship has ended)|Consulting Fee-Merck and Company, Inc.|Consulting Fee-Genentech, Inc. (Relationship has ended)|Consulting Fee-Roche (Relationship has ended)|Consulting Fee-AstraZeneca (Relationship has ended)|Consulting Fee-Eisai, Inc. (Relationship has ended)|Consulting Fee-Eli Lilly and Company (Relationship has ended)|Consulting Fee-EMD Serono (Relationship has ended)
Eileen M O'Reilly, MD
MSK
Faculty
Grant or research support-, AstraZeneca, Arcus, Elicio, Parker Institute, AstraZeneca, Pertzye|Grant or research support-BioNtech|Grant or research support-AstraZeneca|Grant or research support-Arcus|Grant or research support-Parker Institute|Grant or research support-Elicio|Grant or research support-Pertzye|Consulting Fee-Eisai|Consulting Fee-Boehringer Ingelheim Vetmedica GmbH|Consulting Fee-Ipsen|Consulting Fee-Merck and Company, Inc.|Consulting Fee-AstraZeneca|Advisor-Thetis|Advisor-Novartis AG|Advisor-Autem|Advisor-Berry Genomics|Advisor-Exelixis|Advisor-Helio|Advisor-Incyte Corporation|Advisor-Newbridge|Advisor-QED|Advisor-Servier|Advisor-Yiviva|Advisor-Biontech|Advisor-Astellas|Advisor-Neogene|Advisor-Bristol-Myers Squibb|Advisor-Tempus|Advisor-Fibrogen|Advisor-Merus
Rekha Parameswaran, MD
MSK
Faculty
Nothing to disclose
Gregory Riely, MD
MSK
Faculty
Grant or research support-Mirati|Grant or research support-Takeda Pharmaceuticals, Inc.|Grant or research support-Eli Lilly and Company|Grant or research support-Roche|Grant or research support-Pfizer, Inc.|Grant or research support-Merck and Company, Inc.|Grant or research support-Novartis AG
Lindsey Roeker, MD
MSK
Faculty
Consulting Fee-Abbvie|Grant or research support-Abbvie|Consulting Fee-Ascentage|Grant or research support-Adaptive Biotechnologies|Grant or research support-Aptose Biosciences (Relationship has ended)|Consulting Fee-Beigene|Advisor-Abbvie|Consulting Fee-AstraZeneca|Advisor-AstraZeneca|Grant or research support-AstraZeneca|Grant or research support-Genentech, Inc.|Advisor-Janssen|Honoraria-Janssen|Advisor-LOXO oncology|Grant or research support-LOXO oncology|Honoraria-Nurix|Honoraria-Pharmacyclics, Inc.|Honoraria-Pfizer, Inc.|Grant or research support-Pfizer, Inc.|Honoraria-TG Therapeutics (Relationship has ended)|Stocks or stock options, excluding diversified mutual funds-Abbott Laboratories|Stocks or stock options, excluding diversified mutual funds-Abbvie (Relationship has ended)|Grant or research support-DTRM|Grant or research support-Octapharma (Relationship has ended)|Grant or research support-Qilu Puget Sound Biotherapeutics|Grant or research support-Dren Bio
Len B Saltz, MD
MSK
Faculty
Advisor-Genor Biopharma Ltd.
Rachel Sanford, MD
MSK
Faculty
Nothing to disclose
Michael Scordo, MD
MSK
Faculty
Consulting Fee-Omeros Corporation|Grant or research support-Omeros Corporation|Grant or research support-Amgen, Inc.|Consulting Fee-Kite - A Gilead Company (Relationship has ended)|Grant or research support-Angiocrine Bioscience, Inc.|Consulting Fee-Angiocrine Bioscience, Inc. (Relationship has ended)
Susan Seo, MD
MSK
Faculty
Grant or research support-Merck and Company, Inc.
Gunjan Shah, MD, MS
MSK
Faculty
Grant or research support-Johnson and Johnson|Grant or research support-Amgen|Grant or research support-Beyond Spring|Grant or research support-Bristol-Myers Squibb|Review Panel Member-Arcellx
Susan Slovin, MD, PhD
MSK
Faculty
Honoraria-Philips Medical Systems, Inc. (Relationship has ended)|Honoraria-Pfizer, Inc.
Zsofia Stadler, MD
MSK
Faculty
Nothing to disclose
Eytan Stein, MD
MSK
Faculty
Advisor-Celgene (Relationship has ended)|Review Panel Member-Takeda Pharmaceuticals, Inc. (Relationship has ended)|Review Panel Member-Epizyme|Advisor-PinotBio|Advisor-Janssen (Relationship has ended)|Advisor-Bristol-Myers Squibb (Relationship has ended)|Advisor-Agios|Advisor-Jazz|Advisor-Menarini (Relationship has ended)|Advisor-Genentech, Inc.|Advisor-Abbvie|Advisor-Neoleukin (Relationship has ended)|Advisor-Gilead|Consulting Fee-Syndax|Advisor-Genesis Therapeutics|Advisor-OnCusp Therapeutics|Advisor-CTI Biopharma (Relationship has ended)|Advisor-Foghorn Therapeutics (Relationship has ended)|Advisor-Servier|Advisor-Calithera (Relationship has ended)|Review Panel Member-Cellectis|Honoraria-Kura (Relationship has ended)|Advisor-Novartis AG|Advisor-Daiichi Sankyo (Relationship has ended)|Advisor-Aptose (Relationship has ended)|Advisor-Syros (Relationship has ended)|Advisor-Astellas (Relationship has ended)|Advisor-Ono Pharma (Relationship has ended)|Advisor-Debipharm (Relationship has ended)|Advisor-Geomab|Advisor-Janpix|Advisor-Jnana|Advisor-Blueprint (Relationship has ended)
Anna Mary Varghese, MD
MSK
Faculty
Nothing to disclose
Cy R Wilkins, MD
MSK
Faculty
Nothing to disclose
Marjorie G Zauderer, MD
MSK
Faculty
Advisor-Ikena (Relationship has ended)|Advisor-Curis (Relationship has ended)|Grant or research support-GlaxoSmithKline|Grant or research support-Epizyme (Relationship has ended)|Grant or research support-Polaris|Grant or research support-Sellas Life Sciences|Grant or research support-Bristol-Myers Squibb|Grant or research support-Curis|Grant or research support-Atara|Grant or research support-Millennium Pharmaceuticals, Inc. (Relationship has ended)
Andrew D Zelenetz, MD, PhD
MSK
Faculty
Consulting Fee-Genentech, Inc.|Grant or research support-Genentech, Inc.|Grant or research support-Roche|Consulting Fee-Roche|Consulting Fee-MEI Pharma (Relationship has ended)|Grant or research support-MEI Pharma (Relationship has ended)|Advisor-Bristol-Myers Squib Aventis|Consulting Fee-Gilead|Consulting Fee-AstraZeneca|Grant or research support-Beigene|Consulting Fee-Beigene|Advisor-Sandoz (Relationship has ended)|Consulting Fee-Novartis AG|Consulting Fee-AMGEN (Relationship has ended)|Advisor-Janssen (Relationship has ended)|Consulting Fee-Abbvie|Consulting Fee-MorphoSys|Other: DMC Member-Bristol Myers Squibb/Celgene/Juno

Friday, March 10, 2023
SYLLABUS DISCLAIMER
9:00AM - 9:05AM

Please note only the presentations from faculty that have given their consent will be available below. 

Updated on 3/23/23 at 12:00 pm (EST)


MSK CME TERMS OF USE
9:05AM - 9:10AM

By viewing or downloading course materials you are agreeing to MSK CME Program Terms of Use.


Relevant Financial Relationships
9:10AM - 9:15AM

To view faculty disclosures, please visit the course website (mskcc.org/HemOncBoardReview) and select the Faculty tab. All relevant financial relationships have been mitigated prior to the commencement of the activity.


Colon Cancer
9:15AM - 10:00AM
Len B Saltz, MD
Melanoma
10:00AM - 10:45AM
Paul Chapman, MD
Prostate Cancer
10:45AM - 11:30AM
Susan Slovin, MD, PhD
Kidney Cancer
11:30AM - 12:15PM
Robert Motzer, MD
Mesothelioma
12:15PM - 12:30PM
Marjorie G Zauderer, MD
Urothelial Cancer
1:15PM - 2:00PM
Gopa Iyer, MD
Testis Cancer
2:00PM - 2:45PM
Darren Feldman, MD
Uterine/Cervix/Other GYN Cancers
2:45PM - 3:30PM
Carol Aghajanian, MD
Ovarian Cancer
3:45PM - 4:30PM
Rachel Grisham, MD
Breast Cancer: Surgery
4:30PM - 5:00PM
Hiram S Cody III III, MD, FACS
Breast Cancer: Radiation Therapy
5:00PM - 5:30PM
Lior Braunstein, MD
Genetics
5:30PM - 6:00PM
Zsofia Stadler, MD
Saturday, March 11, 2023
Small Cell Lung Cancer
7:00AM - 7:30AM
Naura Choudhury, MD
Breast Cancer: Adjuvant Therapy
7:30AM - 8:30AM
Chau Dang , MD
Breast Cancer: Advanced Disease
8:30AM - 9:30AM
Rachel Sanford, MD
Breast Cancer: Hormonal Therapy
9:30AM - 10:00AM
Devika Gajria, MD
Carcinoma of Unknown Primary
10:00AM - 10:30AM
Anna Mary Varghese, MD
Hepatocellular Cancer and Cholangiocarcinoma
10:45AM - 11:30AM
Ghassan K Abou-Alfa, MD, MBA, Professor
Pancreatic and Neuroendocrine Cancer
11:30AM - 12:15PM
Eileen M O'Reilly, MD
Non Small Cell Lung Cancer
1:00PM - 2:00PM
Gregory Riely, MD
Head and Neck, Thyroid, Non-melanoma Skin Cancer
2:00PM - 3:00PM
Lara Dunn, MD
Anal/Rectal Cancer
3:00PM - 3:30PM
Andrea Cercek, MD
Esophageal/Gastric Cancer
3:45PM - 4:30PM
David Ilson, MD, PhD
CNS Tumors
4:30PM - 5:00PM
Thomas Kaley, MD
Sarcoma
5:00PM - 5:30PM
Mark Dickson, MD
Infectious Disease
5:30PM - 6:00PM
Susan Seo, MD
Sunday, March 12, 2023
Pharmacology I and II
7:30AM - 9:00AM
Mrinal Gounder, MD
CAR T cells
9:10AM - 10:10AM
Michael Scordo, MD
Low-Grade Non-Hodgkin Lymphoma (NHL)
10:10AM - 10:40AM
Andrew D Zelenetz, MD, PhD
Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
10:40AM - 11:10AM
Lindsey Roeker, MD
Diffuse Large B-Cell Lymphoma (DLBCL)/Mantle Cell Lymphoma (MCL)/Burkitt Lymohoma (BL)
11:10AM - 12:10PM
Paul A Hamlin, MD
Hodgkin Lymphoma (HL)/T Cell
12:40PM - 1:40PM
Alison Moskowitz, MD
Auto/Allo
1:40PM - 2:10PM
Gunjan Shah, MD, MS
Acute Lymphoblastic Leukemia (ALL)
2:10PM - 2:40PM
Mark B Blaine Geyer, MD
Acute Myeloid Leukemia (AML)
2:40PM - 3:10PM
Eytan Stein, MD
Myelodysplastic/Myeloprofilerative Neoplasms (MDS/MPN)
3:40PM - 4:40PM
Michael Mauro, MD
Myeloma/Amyloid
4:40PM - 5:40PM
Malin Hultcrantz, MD
Monday, March 13, 2023
Approach to The Bleeding Patient
8:05AM - 9:00AM
Rekha Parameswaran, MD
The Role of the New Direct Oral Anticoagulants in Practice
9:00AM - 10:00AM
Simon Mantha, MD, MPH
Thrombocytopenia, ITP and Beyond
10:00AM - 11:00AM
Cy R Wilkins, MD
Sickle Cell Disease, Thalassemia
11:00AM - 12:00PM
Jodi Mones, MD

MSK CME LINKS

Live Courses
On Demand Courses
Visiting Us
About MSK CME
Contact
Help

ATTENDEE & FACULTY RESOURCES

Course Resources (My CME)
Claim CME Credit for a Live Course
Claim CME Credit for a RSS (MSK employees only)
MSK CME Disclosure Form
MSK CME Faculty Forms

STAY CONNECTED WITH US

Follow MSK CME on Twitter
Like MSK CME on Facebook
Join MSK CME on LinkedIn
Subscribe to MSK CME Course Announcements



MSK CME

mskcc.org | Legal Disclaimer | Privacy Practices | Public Notices
© 2023 Memorial Sloan Kettering Cancer Center